Beyond the Liver: Metabolic Dysfunction Associated Steatotic Liver Disease (MASLD) Associated 35% Higher Risk of Clinically Diagnosed Heart Failure With Preserved Ejection Fraction (HFpEF).
- DOI
- 10.1007/s11886-026-02408-x
- Published
- 2026 Sep 9
- Container
- Current cardiology reports
- Publisher
- Not recorded
- Open access
- no
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1007/s11886-026-02408-x,
title = {Beyond the Liver: Metabolic Dysfunction Associated Steatotic Liver Disease (MASLD) Associated 35\% Higher Risk of Clinically Diagnosed Heart Failure With Preserved Ejection Fraction (HFpEF).},
author = {Hegazy MA and Soliman S and Ahmed MM and Attia A and Bellakhal S and Tawfik NM and Soliman AR},
year = {2026},
journal = {Current cardiology reports},
doi = {10.1007/s11886-026-02408-x},
url = {https://doi.org/10.1007/s11886-026-02408-x}
}RIS
TY - JOUR TI - Beyond the Liver: Metabolic Dysfunction Associated Steatotic Liver Disease (MASLD) Associated 35% Higher Risk of Clinically Diagnosed Heart Failure With Preserved Ejection Fraction (HFpEF). AU - Hegazy MA AU - Soliman S AU - Ahmed MM AU - Attia A AU - Bellakhal S AU - Tawfik NM AU - Soliman AR PY - 2026 JO - Current cardiology reports DO - 10.1007/s11886-026-02408-x UR - https://doi.org/10.1007/s11886-026-02408-x ER -
APA
MA, H., S, S., MM, A., A, A., S, B., NM, T., & AR, S. (2026). Beyond the Liver: Metabolic Dysfunction Associated Steatotic Liver Disease (MASLD) Associated 35% Higher Risk of Clinically Diagnosed Heart Failure With Preserved Ejection Fraction (HFpEF).. Current cardiology reports. https://doi.org/10.1007/s11886-026-02408-x
Source records
- pubmed · retrieved 2026-09-25T03:09:44.734Z
- europe-pmc · retrieved 2026-09-25T03:09:44.773Z